DNA Damage Inducible Transcript 4 Gene: The Switch of the Metabolism as Potential Target in Cancer
DNA damage inducible transcript 4 (DDIT4) gene is expressed under stress situations turning off the metabolic activity triggered by the mammalian target of rapamycin (mTOR). Several in vitro and in vivo works have demonstrated the ability of DDIT4 to generate resistance to cancer therapy. The link b...
Main Authors: | Indira Tirado-Hurtado, Williams Fajardo, Joseph A. Pinto |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2018.00106/full |
Similar Items
-
Expression of mTOR signaling pathway in adrenocortical tumour and its relationship with cell invasion and angiogenesis
by: Sheng-Ping Tian, et al.
Published: (2018-11-01) -
The Potential and Limitations of Precision Oncology: Lessons Learned from Whole-Exome Sequencing in an Exceptional Response to Everolimus in Advanced Renal Cell Carcinoma
by: Amanda Pilling, et al.
Published: (2021-08-01) -
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
by: Zongsheng Duan, et al.
Published: (2018-07-01) -
Potential Mechanisms Connecting Purine Metabolism and Cancer Therapy
by: Jie Yin, et al.
Published: (2018-07-01) -
Akt and mTORC1 signaling as predictive biomarkers for the EGFR antibody nimotuzumab in glioblastoma
by: Michael W. Ronellenfitsch, et al.
Published: (2018-08-01)